These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38968525)

  • 1. Clinical observation of the treatment of refractory cancer pain with cancer pain information platform and IDDS under home analgesia mode: A retrospective study.
    Ding Y; Deng H; Peng J
    Medicine (Baltimore); 2024 Jul; 103(27):e38765. PubMed ID: 38968525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal Drug Delivery Systems for Refractory Pancreatic Cancer Pain: Observational Follow-up Study Over an 11-Year Period in a Comprehensive Cancer Center.
    Carvajal G; Dupoiron D; Seegers V; Lebrec N; Boré F; Dubois PY; Leblanc D; Delorme T; Jubier-Hamon S
    Anesth Analg; 2018 Jun; 126(6):2038-2046. PubMed ID: 29543644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of intrathecal drug delivery system for intractable pain in advanced malignancies: A prospective cohort study.
    Zheng S; He L; Yang X; Li X; Yang Z
    Medicine (Baltimore); 2017 Mar; 96(11):e6354. PubMed ID: 28296770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of intrathecal drug delivery system for refractory cancer pain patients: a single tertiary medical center experience.
    Lin CP; Lin WY; Lin FS; Lee YS; Jeng CS; Sun WZ
    J Formos Med Assoc; 2012 May; 111(5):253-7. PubMed ID: 22656395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids.
    Mercadante S; Intravaia G; Villari P; Ferrera P; Riina S; David F; Mangione S
    Clin J Pain; 2007; 23(9):793-8. PubMed ID: 18075407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal intrathecal analgesia in refractory cancer pain.
    Mastenbroek TC; Kramp-Hendriks BJ; Kallewaard JW; Vonk JM
    Scand J Pain; 2017 Jan; 14():39-43. PubMed ID: 28850428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM).
    Smith TJ; Coyne PJ; Staats PS; Deer T; Stearns LJ; Rauck RL; Boortz-Marx RL; Buchser E; Català E; Bryce DA; Cousins M; Pool GE
    Ann Oncol; 2005 May; 16(5):825-33. PubMed ID: 15817596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal analgesia for severe cancer pain: A retrospective analysis of 60 patients.
    Kiehelä L; Hamunen K; Heiskanen T
    Scand J Pain; 2017 Jul; 16():140-145. PubMed ID: 28850391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Patient-Controlled Intravenous Analgesia with Esketamine for Herpes Zoster Associated with Breakthrough Pain.
    Tang J; Zhang E; Huang B; Fei Y; Yao M
    Pain Physician; 2023 May; 26(3):299-306. PubMed ID: 37192235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cost utilization analysis of intrathecal therapy for refractory cancer pain: identifying factors associated with cost benefit.
    Brogan SE; Winter NB; Abiodun A; Safarpour R
    Pain Med; 2013 Apr; 14(4):478-86. PubMed ID: 23461787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term intrathecal infusion of morphine in the home care of patients with advanced cancer.
    Gestin Y; Vainio A; Pégurier AM
    Acta Anaesthesiol Scand; 1997 Jan; 41(1 Pt 1):12-7. PubMed ID: 9061109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal Drug Delivery Systems for Cancer Pain: An Analysis of a Prospective, Multicenter Product Surveillance Registry.
    Stearns LM; Abd-Elsayed A; Perruchoud C; Spencer R; Hammond K; Stromberg K; Weaver T
    Anesth Analg; 2020 Feb; 130(2):289-297. PubMed ID: 31567325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Intrathecal Analgesia With a Wireless Analgesia Pump System in the Home Care of Patients With Advanced Cancer.
    Liu HJ; Li WY; Chen HF; Cheng ZQ; Jin Y
    Am J Hosp Palliat Care; 2017 Mar; 34(2):148-153. PubMed ID: 26537661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective Analysis of Intrathecal Drug Delivery: Outcomes, Efficacy, and Risk for Cancer-Related Pain at a High Volume Academic Medical Center.
    Sayed D; Monroe F; Orr WN; Phadnis M; Khan TW; Braun E; Manion S; Nicol A
    Neuromodulation; 2018 Oct; 21(7):660-663. PubMed ID: 29446171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pain management, including intrathecal pumps.
    Smith TJ; Swainey C; Coyne PJ
    Curr Oncol Rep; 2004 Jul; 6(4):291-6. PubMed ID: 15161583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal Drug Delivery Systems for Cancer Pain Control: Insights on Current Contemporary Practices in the US.
    Goel V; Kumar V; Blaes A; Gulati A
    Neuromodulation; 2023 Aug; 26(6):1256-1262. PubMed ID: 37318432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective Observational Study of Patient-Controlled Intrathecal Analgesia: Impact on Cancer-Associated Symptoms, Breakthrough Pain Control, and Patient Satisfaction.
    Brogan SE; Winter NB; Okifuji A
    Reg Anesth Pain Med; 2015; 40(4):369-75. PubMed ID: 25923819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable drug delivery systems (IDDS) after failure of comprehensive medical management (CMM) can palliate symptoms in the most refractory cancer pain patients.
    Smith TJ; Coyne PJ
    J Palliat Med; 2005 Aug; 8(4):736-42. PubMed ID: 16128647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term intrathecal opioid therapy with a patient-activated, implanted delivery system for the treatment of refractory cancer pain.
    Rauck RL; Cherry D; Boyer MF; Kosek P; Dunn J; Alo K
    J Pain; 2003 Oct; 4(8):441-7. PubMed ID: 14622664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal Analgesia via a Percutaneous Port With Patient-Controlled Intrathecal Analgesia for the Management of Movement-Evoked Breakthrough Cancer Pain of Refractory Lower Extremity Cancer Pain: A Retrospective Review.
    Zhou L; Guo Z
    Pain Physician; 2023 Jul; 26(4):375-382. PubMed ID: 37535777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.